Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07658222 · ClinicalTrials.gov registry record
Prospective Investigation of Cirrhotic Cardiomyopathy in Humans
A clinical trial, sponsored by Vanderbilt University Medical Center.
- Recruiting
- Registry status
- 440
- Enrollment target
NCT07658222 is a clinical trial that is actively recruiting participants, run by Vanderbilt University Medical Center. The registered enrollment target is 440 participants.
The verdict
NCT07658222 is actively recruiting participants, sponsored by Vanderbilt University Medical Center.
- RECRUITING
- Registry status
- 440 participants
- Enrollment target
Study Summary
Cirrhotic Cardiomyopathy (CCM) is a recognized complication of cirrhosis, but understudied despite recent retrospective data suggesting it may be common, affecting one in three patients with decompensated cirrhosis, and associated with significantly increased risk of death and adverse hepatic and cardiac events. Moreover, evidence from preclinical models and children suggest elevated bile acids in the blood may contribute to CCM, but data from adults with cirrhosis are scarce. Therefore, we are conducting the first contemporary prospective multi-center investigation of CCM in adults in the USA to define CCM risk factors and impact on outcomes while deepening understanding of the role of bile acids in development of this disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 440 participants |
| Start Date | 2026-01-20 |
| Est. Completion | 2030-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07658222
The ClinicalTrials.gov registry entry for NCT07658222 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 440 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT07658222 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07658222 about?
NCT07658222 is a clinical study titled "Prospective Investigation of Cirrhotic Cardiomyopathy in Humans". Cirrhotic Cardiomyopathy (CCM) is a recognized complication of cirrhosis, but understudied despite recent retrospective data suggesting it may be common, affecting one in three patients with decompensated cirrhosis, and associated with significantly increased risk of death and adverse hepatic and ca...
What is the current status of trial NCT07658222?
This trial is currently recruiting. The enrollment target is 440 participants. The study started on 2026-01-20. Estimated completion is 2030-06-30.
Who is sponsoring clinical trial NCT07658222?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.